Carlsmed’s aprevo implant for lumbar spine surgery had reduced complication-related reoperations compared to conventional stock devices, according to two-year data. The study, published in Global ...
Here are 40 spine devices and technologies earning FDA clearances in 2025. Note: This is not an exhaustive list. 1. SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a ...
As spine surgery steadily moves toward outpatient settings, the factors limiting broader adoption are no longer primarily clinical. Advances in surgical technique, anesthesia and pain management have ...
Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for its VyBrate ...
Aurora Spine also announced the issuance of U.S. Patent No. 12,478,481 B2, titled Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use. This patent protects a distinct technology ...
Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating that 3D preoperative planning ...
Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions ...
In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, ...
Best orthopedic tech ROI includes robotic navigation and imaging that improve precision, efficiency, and patient outcomes in spine surgery.
The announcement follows two years of accelerated testing and regulatory navigation. Neuralink launched its first human trial in 2024, two years after the US Food and ...
Renal Denervation procedure across its health system, targeting patients with uncontrolled high blood pressure--a therapy shown in clinical trials to reduce major cardiovascular events by 20%, stroke ...
Australian Associated Press on MSN
Surgeons 'took bribes' for $2.8 million hospital sales
Two surgeons were allegedly offered secret 20 per cent commissions from a company to choose its medical implants when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback